Lauren Savage Fleming's postpartum concerns led her to launch a company addressing a condition most people don't want to talk ...
TipRanks on MSN
Relmada’s BOOST phase 3 bladder cancer trial sets up a new catalyst for RLMD investors
Relmada Therapeutics Inc ($RLMD) announced an update on their ongoing clinical study. Relmada Therapeutics is preparing to launch a late-stage ...
Urinary incontinence (UI) after radical prostatectomy is a common and distressing complication for men with prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback